INTRODUCTION
The American Psychological Association Task Force on Promotion and Dissemination of Psychological Procedures (1993) considered that, in establishing the efficacy of these procedures, to contrast them with a waiting-list control group was not sufficient, and relying on such evidence would leave psychologists at a serious disadvantage compared to psychiatrists. The threat of this disadvantage appears to have increased since 1993 in view of the need for evidence-based treatments established by randomized controlled trials being increasingly accepted by psychiatrists (Geddes & Harrison, 1997) . The Task Force recommended requiring empirical validation of treatments in relation to APA accreditation of internship training and doctoral programs and APA approval of workshops for continuing education credit. Failure to provide methodologically adequate evidence of the efficacy of particular psychological treatments could therefore have serious consequences for the continued use of those treatments and for the esteem in which the treatments and their practitioners are held by other psychologists and psychiatrists.
In articles discussing how to improve the sexual offender treatment outcome literature (Barbaree, 1997; Miner, 1997 ) the use of untreated controls was not discussed, the value of randomized control trials compared to other approaches was questioned, and the use of methodologically doubtful procedures tolerated. In view of the evidence to be discussed that relapse prevention, the most popular model for structuring the treatment of sexual offenders (Hudson & Ward, 1996) , may be at best ineffective and at worst harmful, at least for the majority of sexual offenders, this questioning would seem to be inappropriate and to require examination.
QUESTIONING THE VALUE OF RANDOMIZED CONTROLLED STUDIES
Barbaree (1997) considered that inadequate attention has been paid to the possibility that failures to find treatment effects with sexual offenders could be Type II errors. He pointed out that typically studies of sexual recidivism reported rates of 10 to 40% of untreated offenders reoffending and rarely had subject numbers of treated and untreated offenders exceeded 200. With these numbers, studies are likely to detect a treatment effect at a statistically significant level only when the treated offenders reoffend at less than half the rate of untreated offenders. Barbaree continued that the risks of a Type II error make sense only if there are trends in the data that favor treatment but are not found to be statistically significant. Such trends are of course apparent when the data are reported, so it seems unlikely that most researchers would conclude that treatment was ineffective because a clinically meaningful trend failed to reach statistical significance with the low number of subjects reported in the study. As Barbaree pointed out, when a number of studies report such trends, meta-analysis can be used to demonstrate
